Diarrhea as a Presenting Symptom of Coronavirus Disease 2019 in Children

Borhan Moradveisi1, Pedram Ataee1,2, Alireza Ghaffarieh3

  • 1Department of Pediatrics and Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Insights

Gastroenteritis in children, often caused by infections, can rarely be the sole symptom of coronavirus disease 2019 (COVID-19). This case highlights the diverse and sometimes misleading presentations of COVID-19 in pediatric patients.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Background:

  • Gastroenteritis is a frequent pediatric illness, typically resulting from bacterial, viral, or parasitic infections.
  • Coronavirus disease 2019 (COVID-19) is recognized for its respiratory symptoms, but its presentation in children can vary.
  • Recognizing atypical presentations of infectious diseases is crucial for timely diagnosis and management in pediatric populations.

Observation:

  • A 16-month-old female presented with acute symptoms of vomiting, diarrhea, and lethargy.
  • Initial assessment considered common causes of gastroenteritis in children.
  • The patient's clinical presentation was unusual for typical gastroenteritis.

Findings:

  • Diagnostic testing confirmed the child had contracted coronavirus disease 2019 (COVID-19).
  • Gastroenteritis was the predominant, and seemingly only, clinical manifestation of COVID-19 in this case.
  • This finding underscores the variability in COVID-19 symptomology among pediatric patients.

Implications:

  • The case demonstrates that gastroenteritis can be an isolated symptom of COVID-19 in children.
  • Healthcare providers should consider COVID-19 in the differential diagnosis of unexplained gastroenteritis in pediatric patients.
  • This highlights the importance of considering a broader range of clinical manifestations for COVID-19 in children, even when symptoms appear non-respiratory.

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
332
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
469
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
479
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
574
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
494
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.3K